Literature DB >> 19532083

Prevention of recurrent urinary tract infection in children.

Gabrielle Williams1, Jonathan C Craig.   

Abstract

PURPOSE OF REVIEW: Urinary tract infection (UTI) in children is common (5-10%) and recurs in 10-30%. UTI causes an unpleasant, usually febrile illness in children. This review focuses on studies evaluating interventions to prevent UTI in children and published between January 2007 and June 2008. RECENT
FINDINGS: Three relevant updated Cochrane reviews, six randomized trials and an evidence-based guideline were published in the study period. Five of the six trials and one of the three Cochrane updates included data on the effects of relevant interventions in children. Three of the six trials investigated the efficacy of long-term, low-dose antibiotics as prophylaxis, and the other trials and both Cochrane updates evaluated complementary therapies such as vitamin A, probiotics and herbal supplements.
SUMMARY: The benefit of prophylactic antibiotics for the prevention of recurrent UTI in children remains unclear because of underpowered and suboptimally designed trials, but these studies suggest that any benefit is likely to be small, and clinical significance may be limited. The trials of complementary interventions (vitamin A, probiotics, cranberry, nasturtium and horseradish) generally gave favourable results but were not conclusive. Children and families who use these products should be aware that further infections are possible despite their use.

Entities:  

Mesh:

Year:  2009        PMID: 19532083     DOI: 10.1097/QCO.0b013e328320a885

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  8 in total

1.  Prophylactic antibiotics for children with recurrent urinary tract infections.

Authors:  Joan L Robinson; Jane C Finlay; Mia Eileen Lang; Robert Bortolussi
Journal:  Paediatr Child Health       Date:  2015 Jan-Feb       Impact factor: 2.253

2.  Recurrent urinary tract infections in children: Preventive interventions other than prophylactic antibiotics.

Authors:  Kishor Tewary; Hassib Narchi
Journal:  World J Methodol       Date:  2015-06-26

3.  Molecular characterisation of Escherichia coli isolated from hospitalised children and adults with urinary tract infection.

Authors:  T L Vollmerhausen; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-03       Impact factor: 3.267

Review 4.  Antibiotic prophylaxis in pediatric urology: an update.

Authors:  Saul P Greenfield
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

5.  Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries.

Authors:  N L Ramos; D T N Dzung; K Stopsack; V Jankó; M R Pourshafie; M Katouli; A Brauner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-21       Impact factor: 3.267

Review 6.  Genetic risk for recurrent urinary tract infections in humans: a systematic review.

Authors:  M Zaffanello; G Malerba; L Cataldi; F Antoniazzi; M Franchini; E Monti; V Fanos
Journal:  J Biomed Biotechnol       Date:  2010-03-30

7.  Treatment and prophylaxis in pediatric urinary tract infection.

Authors:  Azar Nickavar; Kambiz Sotoudeh
Journal:  Int J Prev Med       Date:  2011-01

Review 8.  The Contribution of Complementary and Alternative Medicine to Reduce Antibiotic Use: A Narrative Review of Health Concepts, Prevention, and Treatment Strategies.

Authors:  Erik W Baars; Eefje Belt-van Zoen; Thomas Breitkreuz; David Martin; Harald Matthes; Tido von Schoen-Angerer; Georg Soldner; Jan Vagedes; Herman van Wietmarschen; Olga Patijn; Merlin Willcox; Paschen von Flotow; Michael Teut; Klaus von Ammon; Madan Thangavelu; Ursula Wolf; Josef Hummelsberger; Ton Nicolai; Philippe Hartemann; Henrik Szőke; Michael McIntyre; Esther T van der Werf; Roman Huber
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-03       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.